The company plans to meet with the FDA to discuss a rolling approval application for “COMP360,” a synthetic form of psilocybin that could become the first “classic” psychedelic cleared for the U.S.
Compass Pathways shares surged Tuesday after the company said its psilocybin therapy for depression met its primarily goals in recent trials. Shares traded 34% higher ahead of the morning bell at ...
Compass Pathways (CMPS) stock jumps as the company says psychedelic drug COMP360 hit late-stage trial endpoint in ...
Compass Pathways on Tuesday disclosed results from two Phase 3 studies that support a potential approval of its psilocybin treatment for severe depression, but more detailed data are needed to ...
Drug developer Compass Pathways said on Tuesday its psilocybin-based depression therapy met the main goal in a late-stage study.
New York’s RAISE Act was significantly reworked in January 2026, replacing proposed deployment bans with a more targeted ...
When thinking about the American people, columnist David Brooks is a glass-half-full kind of guy.
Compass Minerals (NYSE: CMP), a leading global provider of essential minerals, will release its first-quarter fiscal 2026 results on Wednesday, Feb. 4, 2026, after the markets close. The company’s ...
CAN fuel economy (L/100KM): 10.8/7.8/9.5 Starting Price (USD): $28,380 (inc. dest.) As-Tested Price (USD): $44,305 (inc. dest.) Starting Price (CAD): $32,990 (inc. dest.) As-Tested Price (CAD): ...
Last Friday, Compass, the largest brokerage in the country, acquired Anywhere Real Estate, making it the largest brokerage in the world. Its merger with Anywhere, the second-largest brokerage in the U ...
The real estate industry has a new giant. Compass and Anywhere have officially merged. The companies announced the close of the $1.6 billion deal Friday morning through filings with the Securities and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results